Skip to content Skip to navigation

Publications

Found 327 results
1999
Interstitial MR and CT lymphography with Gd-dTPA-co-alpha, omega-diaminoPEG(1450) and Gd-dTPA-co-1,6-diaminohexane polymers: preliminary experience, Desser, T. S., b>Rubin D. L. </b> <, Muller H., McIntire G. L., Bacon E. R., and Hollister K. R. , Acad Radiol, Feb, Volume 6, Number 2, p.112-8, (1999)
A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical , b>Rubin, D. L. </b> <, Desser T. S., Semelka R., Brown J., Nghiem H. V., Stevens W. R., Bluemke D., Nelson R., Fultz P., Reimer P., et al. , J Magn Reson Imaging, Feb, Volume 9, Number 2, p.240-50, (1999)
A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis, Small, W. C., DeSimone-Macchi D., Parker J. R., Sukerkar A., Hahn P. F., b>Rubin D. L. </b> <, Zelch J. V., Kuhlman J. E., Outwater E. K., Weinreb J. C., et al. , J Magn Reson Imaging, Jul, Volume 10, Number 1, p.15-24, (1999)
Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties, Ladd, D. L., Hollister R., Peng X., Wei D., Wu G., Delecki D., Snow R. A., Toner J. L., Kellar K., Eck J., et al. , Bioconjug Chem, May-Jun, Volume 10, Number 3, p.361-70, (1999)
Safety and efficacy of a new oral contrast agent for sonography: a phase II trial, Lev-Toaff, A. S., Langer J. E., b>Rubin D. L. </b> <, Zelch J. V., Chong W. K., Barone A. E., and Goldberg B. B. , AJR Am J Roentgenol, Aug, Volume 173, Number 2, p.431-6, (1999)
Tool support for authoring eligibility criteria for cancer trials, b>Rubin, D. L. </b> <, Gennari J. H., Srinivas S., Yuen A., Kaizer H., Musen M. A., and Silva J. S. , Proc AMIA Symp, p.369-73, (1999)
1997
Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227, Harisinghani, M. G., Saini S., Weissleder R., Halpern E. F., Schima W., b>Rubin D. L. </b> <, Stillman A. E., Sica G. T., Small W. C., and Hahn P. F. , Radiology, Mar, Volume 202, Number 3, p.687-91, (1997)
A multicenter clinical trial of Gadolite Oral Suspension as a contrast agent for MRI, b>Rubin, D. L. </b> <, Falk K. L., Sperling M. J., Ross M., Saini S., Rothman B., Shellock F., Zerhouni E., Stark D., Outwater E. K., et al. , J Magn Reson Imaging, Sep-Oct, Volume 7, Number 5, p.865-72, (1997)
1995
Adrenal gland enhancement at MR imaging with Mn-DPDP, Mitchell, D. G., Outwater E. K., Matteucci T., b>Rubin D. L. </b> <, Chezmar J. L., and Saini S. , Radiology, Mar, Volume 194, Number 3, p.783-7, (1995)
Gadolinium zeolite as an oral contrast agent for magnetic resonance imaging, Young, S. W., Qing F., b>Rubin D. L. </b> <, Balkus, Jr. K. J., Engel J. S., Lang J., Dow W. C., Mutch J. D., and Miller R. A. , J Magn Reson Imaging, Sep-Oct, Volume 5, Number 5, p.499-508, (1995)
Influence of viscosity on WIN 39996 as a contrast agent for gastrointestinal magnetic resonance imaging, b>Rubin, D. L. </b> <, Muller H. H., Young S. W., Hunke W. A., Gorman W. G., and Lee K. C. , Invest Radiol, Apr, Volume 30, Number 4, p.226-31, (1995)
1994
Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight, Desser, T. S., b>Rubin D. L. </b> <, Muller H. H., Qing F., Khodor S., Zanazzi G., Young S. W., Ladd D. L., Wellons J. A., Kellar K. E., et al. , J Magn Reson Imaging, May-Jun, Volume 4, Number 3, p.467-72, (1994)
Nanoparticulate contrast media. Blood-pool and liver-spleen imaging, b>Rubin, D. L. </b> <, Desser T. S., Qing F., Muller H. H., Young S. W., McIntire G. L., Bacon E., Cooper E., and Toner J. , Invest Radiol, Jun, Volume 29 Suppl 2, p.S280-3, (1994)
Optimization of an oral magnetic particle formulation as a gastrointestinal contrast agent for magnetic resonance imaging, b>Rubin, D. L. </b> <, Muller H. H., Young S. W., Hunke W. A., and Gorman W. G. , Invest Radiol, Jan, Volume 29, Number 1, p.81-6, (1994)
Quantitation of saturation effects versus dose in three-dimensional time-of-flight magnetic resonance angiography with blood-pool contrast agents, Desser, T. S., b>Rubin D. L. </b> <, Fan Q., Muller H. H., Young S. W., Kellar K. E., Wellons J. A., Ladd D. L., Toner J. L., and Snow R. A. , Invest Radiol, Jun, Volume 29 Suppl 2, p.S65-8, (1994)
1993
Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivo, b>Rubin, D. L. </b> <, Muller H. H., Sidhu M. K., Young S. W., Hunke W. A., and Gorman W. G. , J Magn Reson Imaging, Jan-Feb, Volume 3, Number 1, p.113-8, (1993)
1992
Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness, b>Rubin, D. L. </b> <, Muller H. H., and Young S. W. , Magn Reson Med, Jan, Volume 23, Number 1, p.154-65, (1992)
1991
Intraluminal contrast enhancement and MR visualization of the bowel wall: efficacy of PFOB, b>Rubin, D. L. </b> <, Muller H. H., Nino-Murcia M., Sidhu M., Christy V., and Young S. W. , J Magn Reson Imaging, May-Jun, Volume 1, Number 3, p.371-80, (1991)
Methods for the systematic investigation of gastrointestinal contrast media for MRI: evaluation of intestinal distribution by radiographic monitoring, b>Rubin, D. L. </b> <, Muller H. H., and Young S. W. , Magn Reson Imaging, Volume 9, Number 3, p.285-93, (1991)
1990
Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent, Young, S. W., Bradley B., Muller H. H., and b>Rubin D. L. </b> < , Magn Reson Imaging, Volume 8, Number 3, p.267-76, (1990)
Magnetic susceptibility effects and their application in the development of new ferromagnetic catheters for magnetic resonance imaging, b>Rubin, D. L. </b> <, Ratner A. V., and Young S. W. , Invest Radiol, Dec, Volume 25, Number 12, p.1325-32, (1990)
1987
Pulmonary function in advanced pulmonary hypertension, Burke, C. M., Glanville A. R., Morris A. J., b>Rubin D. L. </b> <, Harvey J. A., Theodore J., and Robin E. D. , Thorax, Feb, Volume 42, Number 2, p.131-5, (1987)
1985
Impact of profound reductions of PaO2 on O2 transport and utilization in congenital heart disease, Theodore, J., Robin E. D., Burke C. M., Jamieson S. W., Van Kessel A., b>Rubin D. L. </b> <, Stinson E. B., and Shumway N. E. , Chest, Mar, Volume 87, Number 3, p.293-302, (1985)
Rapid pulmonary dissemination in mycosis fungoides simulating pneumonia. A case report and review of the literature, b>Rubin, D. L. </b> <, and Blank N. , Cancer, Aug 1, Volume 56, Number 3, p.649-51, (1985)
1984
An experimental evaluation of central vs. peripheral injection for intravenous digital subtraction angiography (IV-DSA), b>Rubin, D. L. </b> <, Burbank F. H., Bradley B. R., and Brody W. R. , Invest Radiol, Jan-Feb, Volume 19, Number 1, p.30-5, (1984)
1981
The harmful effects of aqueous contrast agents on the gastrointestinal tract: a study of mechanism and means of counteraction, b>Rubin, D. L. </b> <, Carroll B. A., and Snow H. D. , Invest Radiol, Jan-Feb, Volume 16, Number 1, p.50-8, (1981)
0
Radiology procedure codes in the healthcare enterprise: An overview, Wang, K. C., Patel J. B., Toland M., Collins B., Vreeman D. J., Abheyankar S., Siegel E. L., Rubin D. L., and Langlotz C. P. , Radiographics, (0)

Pages